Does the death knell toll for phlebotomy in NAFLD?
John D. Ryan, Thomas Marjot, Jeremy F. Cobbold – 3 August 2015
Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States
Robert G. Gish, Chari A. Cohen, Joan M. Block, Carol L. Brosgart, Timothy M. Block, Ryan Clary, Loc T. Le, Michael H. Ninburg, Lorren Sandt, Kris V. Kowdley – 3 August 2015
Present and future therapies of hepatitis B: From discovery to cure
T. Jake Liang, Timothy M. Block, Brian J. McMahon, Marc G. Ghany, Stephan Urban, Ju‐Tao Guo, Stephen Locarnini, Fabien Zoulim, Kyong‐Mi Chang, Anna S. Lok – 3 August 2015 – Hepatitis B virus (HBV) is a significant global pathogen, infecting more than 240 million people worldwide. While treatment for HBV has improved, HBV patients often require lifelong therapies and cure is still a challenging goal.
HCV vertical transmission in pregnancy: New horizons in the era of DAAs
Tomi T. Kanninen, Douglas Dieterich, Stefania Asciutti – 3 August 2015
The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique
Gilberto Silva‐Junior, Anna Baiges, Fanny Turon, Ferran Torres, Virginia Hernández‐Gea, Jaime Bosch, Juan Carlos García‐Pagán – 3 August 2015 – Hepatic venous pressure gradient (HVPG), the difference between wedged (WHVP) and free hepatic vein pressure (FHVP), predicts survival in patients with cirrhosis. It has been suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG when the difference between proximal FHVP (obtained at 2 cm from the hepatic vein outlet) and IVC (measured at the level of the hepatic ostium) is >2 mm Hg.
Temoporfin photodynamic therapy in advanced hilar ductal carcinoma: A promising endoscopic modality
Nikhil A. Kumta, Ketisha DeRoche, Michel Kahaleh – 1 August 2015
Correction
1 August 2015
Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi)
Shakeel M. Thakurdas, Mario F. Lopez, Shinako Kakuda, Rodrigo Fernandez‐Valdivia, Neda Zarrin‐Khameh, Robert S. Haltiwanger, Hamed Jafar‐Nejad – 1 August 2015 – Haploinsufficiency for the Notch ligand JAG1 in humans results in an autosomal‐dominant, multisystem disorder known as Alagille syndrome, which is characterized by a congenital cholangiopathy of variable severity.
Patient‐centered care: A new paradigm for chronic liver disease
Manisha Verma, Victor Navarro – 1 August 2015
Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?
Jakob Paur, Lisa Nika, Christiane Maier, Alexander Moscu‐Gregor, Julia Kostka, Daniela Huber, Thomas Mohr, Petra Heffeter, Waltraud C. Schrottmaier, Sonja Kappel, Daniela Kandioler, Klaus Holzmann, Brigitte Marian, Walter Berger, Michael Grusch, Bettina Grasl‐Kraupp – 1 August 2015 – Fibroblast growth factor receptors (FGFRs) are frequently up‐regulated in subsets of hepatocellular carcinoma (HCC). Here, we provide mechanistic insight that FGFR3 splice variants IIIb and IIIc impact considerably on the malignant phenotype of HCC cells.